Novel MedicinesDesigned by EvolutionDiscovered by AI Disease impacts us all…10 million people die will die this year from cancer and 50 million people are projected to die from drug resistant infections every year by 2050 … but making new drugs is difficultDrug discovery is a costly, slow process, often limited to big biopharma that targets...
Focus Area
AI Drug Discovery & Biological Therapeutics Platform
Core Features & Capabilities
Generative Therapeutics Discovery: Combines machine learning and genomics to discover novel biological drugs and peptides.
Antimicrobial & Immune Target Screening: Identifies drug candidates targeting multi-drug resistant pathogens and disease pathways.
In Silico Candidate Optimization: Predicts drug efficacy, toxicity, and binding affinity prior to laboratory synthesis.
Best For
Translating and localizing content across languages
Business OwnersDesignersResearchers
Integrations
MakeLinkedIn
Architecture & Security
Proprietary Bio-AI Platform: Deep learning models integrated with genomic databases and structural biology pipelines.
Pricing Details
Enterprise / Biotech Licensing: Custom commercial partnerships, co-development agreements, and research licensing.
Quick Info
PricingOne-Time
ComplexityAdvanced
DeploymentCloud
Time to ValueTechnical setup required
API AvailableYes
Free TrialNo
Open SourceNo
Compare AMPLY Discovery
Compare features, pricing, and specs side-by-side with top alternatives.
